கொலின் சான்ஃபோர்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கொலின் சான்ஃபோர்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கொலின் சான்ஃபோர்ட் Today - Breaking & Trending Today

Kinnate Biopharma Inc. Closes $35 Million Series A


Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture
May 13, 2021 16:02 ET
| Source:
Kinnate Biopharma
Kinnate Biopharma
Financing led by OrbiMed Asia Partners, with participation from OrbiMed Private Investments and Foresite Capital
The joint venture will have exclusive license to develop and commercialize Kinnate’s currently most advanced kinase inhibitor candidates in Greater China
Veteran biopharmaceutical industry executive Wenn Sun, Ph.D. has been named as Executive Chair
SAN FRANCISCO and SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, announced the closing of a $35 million Series A financing for a joint venture in China. Established with OrbiMed Asia Partners, O ....

United States , Hong Kong , San Diego , San Francisco , Colin Sanford , Kinnate Biopharma , Nima Farzan , Stevend Wang , Wenn Sun , Patti Bank , Lurie Cancer Center , Exchange Commission , University Of Wisconsin , Partner For Oxonc Development , Kinnate Biopharma Inc , Northwestern University , Business Development , National Comprehensive Cancer Network , Orbimed Asia Partners , Orbimed Private Investments , Foresite Capital , Greater China , Med Private Investments , Rapidly Accelerated Fibrosarcoma , Fibroblast Growth Factor Receptors , Senior Managing Director ,

ROSALIND, HELiXrUS and Geninus Partner to Bring Powerful New Single Cell Analysis Services to Cancer Researchers


Press release content from Business Wire. The AP news staff was not involved in its creation.
ROSALIND, HELiXrUS and Geninus Partner to Bring Powerful New Single Cell Analysis Services to Cancer Researchers
April 15, 2021 GMT
SAN DIEGO & SEOUL, South Korea (BUSINESS WIRE) Apr 15, 2021
ROSALIND ®, a software leader in extracting meaningful insights from diverse pools of life science data, today announced that it has partnered with two Seoul-based technology providers to enable a powerful new Single Cell data analysis solution for cancer research scientists in Asia. Geninus, a leading full-service genomics laboratory, will combine the ROSALIND platform with its Celinus™ single cell RNA sequencing service to enable expanded analysis and interpretation of data, as well as seamless sharing and collaboration across labs and geographies. HELiXrUS, a channel partnership company focused on biological big data and multi-omics, played a leading role in establishing this p ....

Soult Ukpyolsi , South Korea , United States , San Diego , Tim Wesselman , Colin Sanford , Geninu Celinus , Samsung Genome Institute , Helixrus Inc , Single Cell , Single Cell Analysis , Genome Biology , Single Cell Gene Expression , Single Cell Immune Profiling , Single Nucleus Gene Expression , Single Cell Multiome , Spatial Gene Expression , Cell Solution , Woong Yang Park , Business Wire , Products And Services , Scientific Research , Pharmaceutical Manufacturing , Health Care Industry , Data Management , New Products And Services ,

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads


Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads
Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II & IIe Systems to their service laboratories
Pacific Biosciences of California, Inc.
Menlo Park, California, UNITED STATES
MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT ....

United States , United Kingdom , City Of , Javier Santoyo Lopez , Colin Sanford , Steve Paterson , Chris Seipert , Pacific Biosciences , David Buck , Pacific Bioscience , Centre For Genomic Research , University Of Edinburgh , University Of Liverpool , California Inc , School Of Biological Sciences , Exchange Commission , Research Use , Oxford Genomics Centre , Pacbio Certified Service Provider Program , University Of Liverpool Centre For Genomic Research , Single Molecule , Liverpool Centre , Genomic Research , Vice President , Bio Hifi , Core Facility ,